Incorporating the lymphocyte-C-reactive protein ratio into risk stratification for intrahepatic cholangiocarcinoma.

Xing K, Wen Y, Yuan S, Lu L

DOI: 10.1080/17520363.2026.2734074
Published: 2026 Sep 14
Container: Biomarkers in medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17520363.2026.2734074,
  title = {Incorporating the lymphocyte-C-reactive protein ratio into risk stratification for intrahepatic cholangiocarcinoma.},
  author = {Xing K and Wen Y and Yuan S and Lu L},
  year = {2026},
  journal = {Biomarkers in medicine},
  doi = {10.1080/17520363.2026.2734074},
  url = {https://doi.org/10.1080/17520363.2026.2734074}
}

RIS

TY  - JOUR
TI  - Incorporating the lymphocyte-C-reactive protein ratio into risk stratification for intrahepatic cholangiocarcinoma.
AU  - Xing K
AU  - Wen Y
AU  - Yuan S
AU  - Lu L
PY  - 2026
JO  - Biomarkers in medicine
DO  - 10.1080/17520363.2026.2734074
UR  - https://doi.org/10.1080/17520363.2026.2734074
ER  -

APA

K, X., Y, W., S, Y., & L, L. (2026). Incorporating the lymphocyte-C-reactive protein ratio into risk stratification for intrahepatic cholangiocarcinoma.. Biomarkers in medicine. https://doi.org/10.1080/17520363.2026.2734074

Source records

pubmed · retrieved 2026-09-27T08:53:42.555Z